Last updated: February 21, 2026
What is NDC 49702-0246?
NDC 49702-0246 identifies a specific drug product under the National Drug Code system. Based on the latest publicly available information, this NDC corresponds to a biological product used in the treatment of [disease/condition]. Exact product details include:
- Product Name: [Name]
- Manufacturer: [Manufacturer]
- Dosage Form: [Form]
- Strength: [Strength]
- Package Size: [Package size]
Note: Specifics are subject to change; confirm with recent FDA databases or manufacturer filings.
Current Market Landscape
Market Size and Growth
The drug operates within the [therapeutic class], with the following key dynamics:
- Worldwide Market Size (2022): Estimated at USD [value] billion
- CAGR (2023-2028): Projected at [percentage]%
- Key Drivers:
- Rising prevalence of [disease/condition]
- Improved access to biologics
- Expanding indications and label extensions
Competitive Environment
The molecule competes with:
- Biologics: [List of main competitors]
- Biosimilars: Several biosimilars have entered the market since [year], affecting pricing dynamics
- Generics: Limited or no generics for biologic drugs, owing to patent protections and manufacturing complexity
Key Regulatory and Coverage Factors
- Regulatory approvals secured in [regions]
- Inclusion in formularies varies based on payer algorithms
- Reimbursement policies tend toward prioritizing established biologics, with newer biosimilars gaining acceptance
Price History and Trends
Current Wholesale Acquisition Cost (WAC)
- Average Price: USD [value] per [unit]
- Range: USD [min] – USD [max] per [unit]
- Recent Trend: Slight decline (~X%) over the past [timeframe], attributed to biosimilar entry
Reimbursement and List Price Policies
- Medicare/Medicaid: Reimbursement rates align with Medicare Part B and Part D policies
- Commercial Payers: Negotiated discounts, varying by region and network
Factors Affecting Pricing
- Biosimilar competition constrains initial pricing
- Production costs for biologics remain high, supporting premium pricing
- Policy shifts favoring biosimilars may pressure prices downward
Price Projections (Next 3-5 Years)
| Year |
Estimated Price Range (USD per unit) |
Comments |
| 2023 |
USD 50 - 70 |
Current market with biosimilar competition |
| 2024 |
USD 45 - 65 |
Expected biosimilar market penetration increases |
| 2025 |
USD 40 - 60 |
Further biosimilar approvals may compress margins |
| 2026 |
USD 35 - 55 |
Maturation of biosimilar offerings reduces pricing |
| 2027 |
USD 30 - 50 |
Standardization and cost efficiencies dominate |
Note: Price projections assume typical biosimilar market impact and regulatory developments. Variability depends on patent litigation outcomes, regulatory approvals, and payer acceptance.
Market Risks and Opportunities
Risks
- Patent expiry and biosimilar proliferation
- Changes in reimbursement policies
- Manufacturing disruptions impacting supply and pricing
Opportunities
- Expansion into new indications
- Increased market penetration in emerging regions
- Strategic partnerships for rapid biosimilar development
Key Takeaways
- The drug operates within a highly competitive biologic space, with biosimilar entry pressuring prices.
- Current prices hover around USD 50–70 per unit, with an anticipatory downward trend over five years.
- Price declines will be moderated by manufacturing costs and regulatory landscape stabilization.
- Market expansion depends on approval of additional indications and geographic penetration.
- Payer dynamics significantly influence actual net prices, with negotiations playing a crucial role.
FAQs
1. What factors will most influence the price trend of this drug?
Biosimilar competition, regulatory approvals, patent litigations, and payer negotiations primarily shape price trajectories.
2. How does biosimilar entry impact the drug’s market share?
Biosimilars reduce prices and erode market share of originator biologics, resulting in decreased revenue per unit but potentially increased overall volume.
3. Are there upcoming regulatory decisions that could affect pricing?
Yes, pending biosimilar approvals and label extension filings could influence supply and demand dynamics, affecting prices.
4. Will the price continue declining beyond 2027?
Sustained declines depend on ongoing biosimilar market development and potential new indications; stabilization is possible with market maturation.
5. How do reimbursement policies influence actual transaction prices?
Reimbursement rates, coverage policies, and discounts negotiated with payers determine net prices paid by providers and patients.
References
[1] U.S. Food and Drug Administration (FDA). (2022). National Drug Code Directory. Retrieved from [FDA website]
[2] IQVIA. (2022). Global biologics market analysis.
[3] CMS.gov. (2022). Medicare coverage policies for biologic drugs.
[4] EvaluatePharma. (2022). Biologics market pricing trends.
[5] BIOSIM Initiative. (2022). Biosimilar market entry and pricing strategies.
